Dr. Scott M. Bradfield
Claim this profileAlfred I duPont Hospital for Children
Expert in Cancer
Expert in Brain Tumor
44 reported clinical trials
81 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
NTRK1 positive
NTRK positive
2Brain Tumor
Global LeaderStage I
Stage II
NTRK1 positive
Affiliated Hospitals
Clinical Trials Scott M. Bradfield is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Scott M. Bradfield
Clinical Trial Related7 years of experience running clinical trials · Led 44 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Scott M. Bradfield has experience with
- Radiation Therapy
- Cyclophosphamide
- Larotrectinib
- Dactinomycin
- Vincristine Sulfate
- Cisplatin
Breakdown of trials Scott M. Bradfield has run
Cancer
Brain Tumor
Benign Glioma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott M. Bradfield specialize in?
Scott M. Bradfield focuses on Cancer and Brain Tumor. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are NTRK1 positive.
Is Scott M. Bradfield currently recruiting for clinical trials?
Yes, Scott M. Bradfield is currently recruiting for 17 clinical trials in Wilmington Delaware. If you're interested in participating, you should apply.
Are there any treatments that Scott M. Bradfield has studied deeply?
Yes, Scott M. Bradfield has studied treatments such as Radiation Therapy, Cyclophosphamide, Larotrectinib.
What is the best way to schedule an appointment with Scott M. Bradfield?
Apply for one of the trials that Scott M. Bradfield is conducting.
What is the office address of Scott M. Bradfield?
The office of Scott M. Bradfield is located at: Alfred I duPont Hospital for Children, Wilmington, Delaware 19803 United States. This is the address for their practice at the Alfred I duPont Hospital for Children.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.